Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-057-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
A prenatal developmental toxicity study was performed on an analogue substance. As no effects were observed in females in this study, no additional reproduction toxicity study was performed on the registered substance. NOAEL(maternal - analogue) > 1000 mg/kg bw/day ; NOAEL(maternal - registered substance, corrected by MM) > 1781.45 mg/kg bw/day
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 781.45 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Prenatal/developmental toxicity study performed on an analogue substance (OECD 414, GLP, rel.1).
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No study was available on the substance itself, therefore a read-across approach was used.
In a Prenatal developmental toxicity study performed in accordance with OECD test guideline No. 414 and in compliance with GLP, an analogue substance was administered daily by oral gavage to SPF-bred Wistar rats (22 mated females per group) at dose levels of 100, 300 and 1000 mg/kg bw/day from day 1 post coitum (after mating) to day 20 post coitum (the day prior to Caesarean section). A control group was treated similarly with the vehicle, Milli-Q-Water. All females were sacrificed on day 21 post coitum and the fetuses were removed by Caesarean section. During the study, clinical condition, body weight, food consumption, macropathology investigations were undertaken on dams.
All dams survived until the scheduled necropsy. No clinical symptoms related to treatment with the test item were noted during the study. Mean food consumption, mean body weight and corrected body weight gain (corrected for the gravid uterus weight) were not affected by treatment with the test item in any dose group. Post-implantation losses and the mean number of fetuses per dam were not affected by treatment with the test item at any dose level. No macroscopical findings were noted during necropsy of the dams.
NOEL for maternal and fetal toxicity was considered to be 1000 mg/kg bw/day
Based on the results of this study performed on an analogue substance, the NOAEL of the registered substance for maternal toxicity was considered to be higher than 1781.45 mg/kg bw/day.
Effects on developmental toxicity
Description of key information
Prenatal Developmental Toxicity Study on analogue substance (OECD 414, GLP, K, rel.1): NOAEL(analogue)= 1000 mg/kg bw/day ; NOAEL(registered substance, corrected by MM) = 1781.45 mg/kg bw/day
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 781.45 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The key study performed on an analogue substance is GLP-compliant and of high quality (Klimisch score = 1).
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No study was available on the substance itself, therefore a read-across approach was used.
A key study was identified (Harlan, 2010). In a Prenatal developmental toxicity study performed in accordance with OECD test guideline No. 414 and in compliance with GLP, an analogue substance was administered daily by oral gavage to SPF-bred Wistar rats (22 mated females per group) at dose levels of 100, 300 and 1000 mg/kg bw/day from day 1 post coitum (after mating) to day 20 post coitum (the day prior to Caesarean section). A control group was treated similarly with the vehicle, Milli-Q-Water. All females were sacrificed on day 21 post coitum and the fetuses were removed by Caesarean section. During the study, external examination, sex ratios, body weights, visceral examination, skeletal and cartilage examination were performed on fetuses.
During the external examination of the fetuses, no test item-related abnormal findings were noted. No test item-related effects on fetal sex ratios were noted in any dose group. No test item-related effects on fetal body weights were noted. No test item-related abnormalities were noted during the visceral examination of fetuses. No abnormalities, which were considered to be test item-related, were noted during examination of fetal skeletons and cartilages.
NOEL for maternal and fetal toxicity was considered to be 1000 mg/kg bw/day
Based on the results of this study performed on an analogue substance, the NOAEL of the registered substance for fetal toxicity was considered to be higher than 1781.45 mg/kg bw/day.
Moreover, in the HERA report on Esterquats of November 2009, in a developmental toxicity study performed on Hamburg Ester Quat (HEQ), another analogue of the registered substance, the NOAEL is 1000 mg/kg bw/day ( maximum tested).
Reference:HERA (2009). Human and Environmental Risk Assessment on Ingredients of Household Cleaning Products (HERA), Avenue Herrmann Debroux ISA, B-1160 Brussels Belgium. Edition 1.0 November 2009. Esterquats Human Health Risk Assessment Report. <http://www.heraproject.com/files/17-HH-HERA-EQ-HH-TM-finalDraft-24Nov%20web.pdf>.
Justification for classification or non-classification
Harmonized classification:
The substance has no harmonized classification according to the Regulation (EC) No 1272/2008.
Self classification:
Based on the available data, no self-classification is proposed regarding the toxicity on fertility or on development after oral dose-repeated exposure according to the Annex VI of the Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)